Effects of linagliptin (LINA) versus glimepiride (GLIM) on cognitive performance in type 2 diabetes: the CAROLINA COGNITION study

被引：0
|
作者：
Biessels, G. J. [1 ]
Verhagen, C. [1 ]
Janssen, J. [1 ,2 ]
van den Berg, E. [1 ,3 ]
Passera, A. [4 ]
Wallenstein, G. [5 ]
Zinman, B. [6 ]
Espeland, M. E. [7 ]
Johansen, O. E. [8 ]
机构：
[1] UMC Utrecht Brain Ctr, Utrecht, Netherlands
[2] UMC Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
[3] UMC, Erasmus MC, Rotherdam, Netherlands
[4] HMS Analyt Software GmbH, Sulzbach, Germany
[5] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany
[6] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada
[7] Wake Forest Sch Med, Winston Salem, NC 27101 USA
[8] Boehringer Ingelheim GmbH & Co KG, Asker, Norway
来源：
DIABETOLOGIA | 2019年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
583
引用
收藏
页码：S281 / S282
页数：2
相关论文
共 50 条
  • [1] Effects of linagliptin vs glimepiride stratified by prior insulin secretagogue use in the cardiovascular outcome study of linagliptin versus glimepiride in type 2 diabetes (CAROLINA) trial
    McGuire, D. K.
    Rosenstock, J.
    Johansen, O. E.
    Zinman, B. J.
    Khunti, K.
    Mattheus, M.
    Lund, S. S.
    Espeland, M. A.
    Marx, N.
    EUROPEAN HEART JOURNAL, 2020, 41 : 3356 - 3356
  • [2] Effects of linagliptin vs glimepiride on cognitive performance in type 2 diabetes: results of the randomised double-blind, active-controlled CAROLINA-COGNITION study
    Geert Jan Biessels
    Chloë Verhagen
    Jolien Janssen
    Esther van den Berg
    Gudrun Wallenstein
    Bernard Zinman
    Mark A. Espeland
    Odd Erik Johansen
    Diabetologia, 2021, 64 : 1235 - 1245
  • [3] Effects of linagliptin vs glimepiride on cognitive performance in type 2 diabetes: results of the randomised double-blind, active-controlled CAROLINA-COGNITION study
    Biessels, Geert Jan
    Verhagen, Chloe
    Janssen, Jolien
    van den Berg, Esther
    Wallenstein, Gudrun
    Zinman, Bernard
    Espeland, Mark A.
    Johansen, Odd Erik
    DIABETOLOGIA, 2021, 64 (06) : 1235 - 1245
  • [4] Rationale and design of the CAROLINA®-cognition substudy: a randomised controlled trial on cognitive outcomes of linagliptin versus glimepiride in patients with type 2 diabetes mellitus
    Biessels, Geert Jan
    Janssen, Jolien
    van den Berg, Esther
    Zinman, Bernard
    Espeland, Mark A.
    Mattheus, Michaela
    Johansen, Odd Erik
    BMC NEUROLOGY, 2018, 18
  • [5] Rationale and design of the CAROLINA® - cognition substudy: A randomised controlled trial on cognitive outcomes of linagliptin versus glimepiride in patients with type 2 diabetes mellitus
    Biessels G.J.
    Janssen J.
    van den Berg E.
    Zinman B.
    Espeland M.A.
    Mattheus M.
    Johansen O.E.
    BMC Neurology, 18 (1)
  • [6] Baseline characteristics of participants enrolled in the cardiovascular outcome study of linagliptin versus glimepiride in early type 2 diabetes (CAROLINA)
    Marx, N.
    Rosenstock, J.
    Kahn, S. E.
    Zinman, B.
    Kastelein, J. J.
    Lachin, J.
    Espeland, M. A.
    Bluhmki, E.
    Mattheus, M.
    Patel, S.
    Johansen, O.
    Woerle, H. -J.
    DIABETOLOGIA, 2013, 56 : S36 - S37
  • [7] Design and baseline characteristics of the CARdiovascular Outcome Trial of LINAgliptin Versus Glimepiride in Type 2 Diabetes (CAROLINA®)
    Marx, Nikolaus
    Rosenstock, Julio
    Kahn, Steven E.
    Zinman, Bernard
    Kastelein, John J.
    Lachin, John M.
    Espeland, Mark A.
    Bluhmki, Erich
    Mattheus, Michaela
    Ryckaert, Bart
    Patel, Sanjay
    Johansen, Odd Erik
    Woerle, Hans-Juergen
    DIABETES & VASCULAR DISEASE RESEARCH, 2015, 12 (03): : 164 - 174
  • [8] Baseline Characteristics of Participants Enrolled in the CARdiovascular Outcome Study of LINAgliptin versus Glimepiride in Early Type 2 Diabetes (CAROLINA)
    Marx, Nikolaus
    Rosenstock, Julio
    Kahn, Steven
    Zinman, Bernard
    Kastelein, John J.
    Lachin, John M.
    Bluhmki, Erich
    Mattheus, Michaela
    Patel, Sanjay
    Johansen, Odd Erik
    Woerle, Hans-Juergen
    DIABETES, 2013, 62 : A602 - A602
  • [9] Linagliptin and Glimepiride Equally Effective for Adults with Type 2 Diabetes Mellitus
    Slawson, David C.
    AMERICAN FAMILY PHYSICIAN, 2020, 101 (05) : 309 - 310
  • [10] Linagliptin versus placebo followed by glimepiride in type 2 diabetes patients with moderate to severe renal impairment
    Groop, P. -H.
    Laakso, M.
    Rosenstock, J.
    Hehnke, U.
    Tamminen, I.
    Patel, S.
    von Eynatten, M.
    Woerle, H. -J.
    DIABETOLOGIA, 2013, 56 : S364 - S365
12345